Prothena Corporation plc (PRTA)
NASDAQ: PRTA · Real-Time Price · USD
5.06
+0.18 (3.69%)
Jun 5, 2025, 4:00 PM - Market closed
Prothena Corporation Market Cap
Prothena Corporation has a market cap or net worth of $272.36 million as of June 5, 2025. Its market cap has decreased by -77.62% in one year.
Market Cap
272.36M
Enterprise Value
-135.37M
1-Year Change
-77.62%
Ranking
Category
Stock Price
$5.06
Market Cap Chart
Since December 21, 2012, Prothena Corporation's market cap has increased from $127.30M to $272.36M, an increase of 113.95%. That is a compound annual growth rate of 6.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2025 | 272.40M | -63.45% |
| Dec 31, 2024 | 745.30M | -61.78% |
| Dec 29, 2023 | 1.95B | -33.09% |
| Dec 30, 2022 | 2.91B | 26.63% |
| Dec 31, 2021 | 2.30B | 380.02% |
| Dec 31, 2020 | 479.50M | -24.08% |
| Dec 31, 2019 | 631.60M | 53.82% |
| Dec 31, 2018 | 410.60M | -71.51% |
| Dec 29, 2017 | 1.44B | -15.04% |
| Dec 30, 2016 | 1.70B | -20.98% |
| Dec 31, 2015 | 2.15B | 277.66% |
| Dec 31, 2014 | 568.50M | -1.92% |
| Dec 31, 2013 | 579.60M | 347.22% |
| Dec 31, 2012 | 129.60M | 1.81% |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 674.00B |
| Johnson & Johnson | 371.55B |
| AbbVie | 330.76B |
| Novo Nordisk | 315.80B |
| UnitedHealth Group | 273.25B |
| Abbott Laboratories | 232.63B |
| Novartis AG | 226.74B |
| AstraZeneca | 223.00B |